| Cash Flow | 2025-09-30 |
|---|---|
| Cash received from customers | 1,958,700 |
| Cash paid to suppliers and employees | 1,511,400 |
| Interest paid, net | 45,500 |
| Income tax payments, net | 54,300 |
| Investment proceeds and miscellaneous receipts, net | 62,700 |
| Proceeds from forward foreign exchange contracts, net | 42,900 |
| Net cash provided by operating activities | 367,300 |
| Capital expenditures | 111,800 |
| Proceeds from dispositions of property, plant and equipment | 100 |
| Payments for previous acquisition | 218,500 |
| Payments for acquired in-process research and development | 0 |
| Payments for purchases of marketable securities and investments | 530,500 |
| Proceeds from sale of debt securities, available-for-sale | 646,200 |
| Proceeds from maturities of marketable securities and investments | 59,000 |
| Net cash used in investing activities | -155,500 |
| Payments on long-term borrowings | 300 |
| Payments for debt issuance costs | 0 |
| Proceeds from issuance of common stock | 11,900 |
| Payment, tax withholding, share-based payment arrangement | 2,600 |
| Payments for purchases of treasury stock | 295,500 |
| Net cash used in financing activities | -286,500 |
| Effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents | -16,900 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | -91,600 |
| Cash and cash equivalents at beginning of period | 489,800 |
| Cash and cash equivalents at end of period | 398,200 |
BIO-RAD LABORATORIES, INC. (BIO-B)
BIO-RAD LABORATORIES, INC. (BIO-B)